|
|
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study.
Mira Tout
,
Olivier Casasnovas
,
Michel Meignan
,
Thierry Lamy
,
Franck Morschhauser
et al.
Article dans une revue
hal-01547802v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia
Pierre Feugier
,
Thérèse Aurran
,
Beatrice Mahe
,
Remi Letestu
,
Florence C Nguyen-Khac
et al.
Article dans une revue
hal-01860422v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition
Amina Bensalem
,
Guillaume Cartron
,
Ulrich Specks
,
Denis Mulleman
,
Emmanuel Gyan
et al.
Article dans une revue
hal-03482193v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group
Christophe Bonnet
,
Jehan Dupuis
,
Hervé Tilly
,
Thierry Lamy
,
Christophe Fruchart
et al.
Article dans une revue
hal-03660656v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients
Anne-Ségolène Cottereau
,
Tarec C El-Galaly
,
Stéphanie Becker
,
Florence Broussais
,
Lars Jelstrup Peterson
et al.
Article dans une revue
hal-01643956v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
Laetitia Vercellino
,
Roberta Di Blasi
,
Salim Kanoun
,
Benoit Tessoulin
,
Cedric Rossi
et al.
Article dans une revue
hal-03226567v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ibrutinib, Obinutuzumab And Venetoclax In Relapsed and Untreated Patients with Mantle-Cell Lymphoma, a phase I/II trial
Steven Le Gouill
,
Franck Morschhauser
,
David Chiron
,
Krimo Bouabdallah
,
Guillaume Cartron
et al.
Article dans une revue
inserm-03063717v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Report of the 6th International Workshop on PET in lymphoma
Cristina Nanni
,
Anne Ségolène Cottereau
,
Egesta Lopci
,
Caroline Bodet-Milin
,
Monica Coronado
et al.
Article dans une revue
hal-01716432v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia
Cécile Tomowiak
,
Stéphanie Poulain
,
Charles Herbaux
,
Aurore Perrot
,
Béatrice Mahé
et al.
Article dans une revue
hal-03251785v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Louis Berthet
,
Alexandre Cochet
,
Salim Kanoun
,
Alina Berriolo-Riedinger
,
Olivier Humbert
et al.
Article dans une revue
hal-00927556v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells
Jean Galtier
,
Laetitia Vercellino
,
Loic Chartier
,
Pierre Olivier
,
Claire Tabouret-Viaud
et al.
Article dans une revue
inserm-03924745v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post autologous stem cell transplantation brentuximab vedotin maintenance : a French multicenter observational cohort study
Amira Marouf
,
Anne Segolene Cottereau
,
Salim Kanoun
,
Paul Deschamps
,
Michel Meignan
et al.
Article dans une revue
hal-03628340v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
[18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
Salim Kanoun
,
Cédric Rossi
,
Olivier Casasnovas
Article dans une revue
hal-01922795v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic value of baseline metabolic tumor volume in early stage Hodgkin's lymphoma in the standard arm of H10 trial
Anne Ségolène Cottereau
,
Annibale Versari
,
Annika Loft
,
Olivier Casasnovas
,
Monica Bellei
et al.
Article dans une revue
hal-01738084v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC / PVT1 predicts patient outcome in two independent cohorts
Hervé Ghesquières
,
Beth R. Larrabee
,
Olivier Casasnovas
,
Matthew Maurer
,
James D. Mckay
et al.
Article dans une revue
hal-01728832v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Good clinical practice recommendations for the use of PET/CT in oncology
Pierre-Yves Salaün
,
Ronan Abgral
,
Olivier Malard
,
Solène Querellou-Lefranc
,
Gilles Quere
et al.
Article dans une revue
hal-03125498v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres
Hervé Ghesquières
,
Cécile Dalban
,
Emmanuelle Nicolas‐virelizier
,
Fabrice Jardin
,
Fabien Le Bras
et al.
Article dans une revue
inserm-03349131v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial
Benoit Tessoulin
,
David Chiron
,
Catherine Thieblemont
,
Lucie Oberic
,
Kamal Bouadballah
et al.
Article dans une revue
hal-03203334v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
Michael Wang
,
Simon Rule
,
Pier Luigi Zinzani
,
Andre Goy
,
Olivier Casasnovas
et al.
Article dans une revue
inserm-01980627v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies
Julien Magne
,
Alizée Jenvrin
,
Adrien Chauchet
,
Olivier Casasnovas
,
Anne Donzel
et al.
Article dans une revue
hal-01731294v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
“Staging, restaging and treatment response assessment” in lymphomas: what we should know.
Salim Kanoun
,
Anne-Ségolène Cottereau
,
Alina Berriolo-Riedinger
,
Michel A. Meignan
,
Olivier Casasnovas
et al.
Article dans une revue
hal-01689923v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?
Anne-Ségolène Cottereau
,
Irène Buvat
,
Salim Kanoun
,
Annibale Versari
,
Olivier Casasnovas
et al.
Autre publication scientifique
hal-01824888v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|